Migralex, Inc.

Developed by world renowned neurologist, Migralex is the only patented analgesic with superior efficacy and a safer profile. 94% IRR, 11.5x Cash, 2.5yr Payback.

  • Stage Full Product Ready
  • Industry Consumer Products
  • Location New York, NY, US
  • Currency USD
  • Website trymigralex.com

Company Summary

The Company is a producer of migraine treatment medication and was founded by a world renowned neurologist who has invested $5.5 million to date.

Migralex Inc. is seeking $3 million USD in preferred equity financing. Migralex already has two headache medication products in the market which have generated close to $1m in cumulative sales.

Visit www.trymigralex.com

Team

  • Investor Relations

  • Alexander Mauskop
    Founder

    - Founder and Director of New York Headache Center
    - Fellow of the American Academy of Neurology & American Headache Society
    - Professor of Clinical Neurology at SUNY, Downstate Medical Center

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free